Product Information

MIRABEGRON ER 50 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $8.9858 per EA under NDC 68180015209. Its NADAC has been published 108 times since Oct 30, 2024.

FDA first approved this application on Sep 28, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MIRABEGRON ER 50 MG TABLET

mirabegron
$8.9858per EA

Strength

50 mg/1

NDC

68180015209

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MIRABEGRON

Approval Type

Generic (ANDA)

FDA Application

ANDA209485

FDA Approved

9/28/2022

TE Code

AB

On Market Since

9/3/2024

Pharmacological Classes

Adrenergic beta3-Agonists
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors
beta3-Adrenergic Agonist

Price Statistics

The NADAC for MIRABEGRON ER 50 MG TABLET has been published 108 times since Oct 30, 2024, and over the history we have for it it has declined 21.0%. The table below summarizes its recorded NADAC range and movement.

Current price$8.9858 per EA
All-time high$11.3806 (Nov 13, 2024)
All-time low$8.9858 (Nov 18, 2026)
52-week high$9.7568
52-week low$8.9858
Median price$9.6695
Average price$9.8150
Largest weekly change-7.7% (Nov 20, 2024)
Weeks tracked108
Tracking sinceOct 30, 2024

Price History

1W

-1.8%

1M

-4.3%

3M

-6.4%

6M

-7.7%

1Y

-6.1%

3Y

N/A

5Y

N/A

All

-21.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIRABEGRON ER 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIRABEGRON ER 50 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $8.9858 per EA (NDC 68180015209), effective Nov 18, 2026.

How has the price of MIRABEGRON ER 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIRABEGRON ER 50 MG TABLET has declined 21.0%. It has been tracked across 108 weekly CMS publications since Oct 30, 2024.

What are the highest and lowest recorded NADAC prices for MIRABEGRON ER 50 MG TABLET?

Since Oct 30, 2024, the NADAC for MIRABEGRON ER 50 MG TABLET has ranged from a low of $8.9858 (Nov 18, 2026) to a high of $11.3806 (Nov 13, 2024), with a median of $9.6695 per EA.

Are there cheaper alternatives to MIRABEGRON ER 50 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIRABEGRON ER 50 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIRABEGRON ER 50 MG TABLET?

MIRABEGRON ER 50 MG TABLET (NDC 68180015209) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.